跳至主要内容
临床试验/NL-OMON44666
NL-OMON44666已完成不适用

Clonidine Augmentation Treatment in Schizophrenia - CATS-Study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. A DSM-IV-R diagnosis of: 295.x (schizophrenia), schizophreniform disorder, or schizoaffective disorder)
  • 3. A total PANSS score of at least 55
  • 4. Age 18-50 years.
  • 5. Patients are treated with antipsychotic medication
  • 6. Written informed consent
  • 7. Female patients of childbearing potential need to utilize a proper method of contraception
  • 8. (oral anticonceptives, vaginal ring, hormonal patch, intrauterine device, cervical cap, condom, contraceptive injection, diaphragm) in case of sexual intercourse during the study.
  • Ad. A priority will be given to patients who achieve no or only partial response to clozapine as defined by a total PANSS score of at least 80.;Inclusion criteria healthy controls:
  • -Age between 18-50 years
  • -Good Physical and Mental Health meeting criteria never mentally ill, which will be evaluated with a medical history checklist;
  • -Age between 18 and 45 years;
  • -Written informed consent of the subject.

排除标准

  • 1. Presence of any of the contra-indications of clonidine as reported in the Summary of Product Characteristics (SPC).
  • 2. Supine systolic blood pressure (SSBP) < 85 mm HG
  • 3. Pre-existent orthostatic hypotension with a drop of systolic blood pressure of > 20 mmHg or a drop of diastolic blood pressure of >10 mmHg.
  • 4. Supine heart rate (SHR) < 50 beats/min
  • 5. Severe brady-arhytmias such as sick-sinussyndroom, second or third degree AV-block.
  • 6. Pregnancy or breast-feeding. A urine pregnancy test will be performed at screening.
  • 7. The use of drugs that affect the (nor)adrenergic system such as beta-blockes and mirtazapine.;Exclusion criteria healthy controls:
  • -Current use of any medication prescribed medication exclusive oral anticonceptives;
  • -Any subject who has received any investigational medication within 30 days prior to the start of this study;
  • -History of neurologic illness; History of psychiatric illness in first-degree relatives, evaluated with DSM-IV criteria;
  • -History of alcohol and drug abuse;
  • -BMI below 18.5.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

Clonidine Augmentation Treatment in Schizophrenia | 临床试验